Risk management of metabolic disorders in the use of antipsychotics

Autor:	G. E. Mazo, A. O. Kibitov
Jazyk:	ruština
Rok vydání:	2018
Předmět:	метаболические нарушения антипсихотики индуцируемая антипсихотиками прибавка веса терапевтический менеджмент зипрасидон adverse metabolic effects antipsychotics antipsychotic-inducedweightgain therapeutic management ziprasidone Psychiatry RC435-571
Zdroj:	Обозрение психиатрии и медицинской психологии имени В.М. Бехтерева, Vol 0, Iss 3, Pp 85-97 (2018)
Druh dokumentu:	article
ISSN:	2313-7053 2713-055X
Popis:	Cardio-metabolic risk factors and diabetes mellitus type 2 are highly prevalent in patients with schizophrenia. Decrease of metabolic risks associated with use of atypical antipsychotics is connected with the development of specialised programs. They can prevent and treat metabolic disorders. This article presents a comprehensive approach to the problem and proposes a solution to minimise the risk of metabolic disorders. The analysis dependence risk of formation of metabolic disorders with genetic factors, behavioral disorders, associated with schizophreniaand therapypresented in the article.
Databáze:	Directory of Open Access Journals
Externí odkaz:	https://doaj.org/article/a5adafaebbf3416eaf79986f1c5ad2ec Zobrazit plný text záznamu View record in DOAJ